Literature DB >> 34840644

Biophotonic Therapy with Fluorescent Light Energy Decreases Facial Erythema, Improves Signs and Symptoms of Rosacea, and Increases Patient Satisfaction: A Postmarket Study.

Martin Wade1,2, Vanessa Charest1,2, Bruno Ballardin1,2, Deirdre Edge1,2, Michael Canova Engelbrecht Nielsen1,2.   

Abstract

BACKGROUND: Rosacea is a difficult-to-manage chronic inflammatory skin condition reported to have a negative psychosocial impact on patients. Novel approaches are sought to target the many signs and symptoms of the condition while also improving the quality of life of patients.
OBJECTIVE: We assessed the efficacy of the Kleresca® biophotonic platform (KLOX Technologies Inc., Laval, Canada), which creates fluorescent light energy (FLE), to induce a novel form of photobiomodulation for treating rosacea. We also assessed patient satisfaction with their facial appearance and concerns about perceptions of others before and after treatment.
METHODS: Nine patients were treated once a week for four weeks with FLE. Patients and the treating clinician completed questionnaires throughout and after the treatment to grade the rosacea signs and symptoms and capture patients' perceptions of the treatment and their condition.
RESULTS: FLE significantly reduced the inflammatory erythematous reaction of the face, improved flushing and erythema associated with rosacea, and had a positive impact on patients' self-perception and emotional wellbeing.
CONCLUSION: Our results support FLE as an effective, noninvasive treatment modality for rosacea.
Copyright © 2021. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  FLE; Rosacea; biophotonics; chromophore; erythema; fluorescent light energy; flushing; inflammatory skin conditions; patient perception; photobiomodulation; quality of life; questionnaire; skin quality

Year:  2021        PMID: 34840644      PMCID: PMC8570353     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  29 in total

Review 1.  Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics.

Authors:  Anna D Holmes; Martin Steinhoff
Journal:  Exp Dermatol       Date:  2016-10-09       Impact factor: 3.960

Review 2.  Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee.

Authors:  Richard L Gallo; Richard D Granstein; Sewon Kang; Mark Mannis; Martin Steinhoff; Jerry Tan; Diane Thiboutot
Journal:  J Am Acad Dermatol       Date:  2017-10-28       Impact factor: 11.527

3.  Cross-Sectional Survey of the Burden of Illness of Rosacea by Erythema Severity.

Authors:  Julie Harper; James Q Del Rosso; Ilia L Ferrusi
Journal:  J Drugs Dermatol       Date:  2018-02-01       Impact factor: 2.114

4.  FLUORESCENT LIGHT ENERGY: The Future for Treating Inflammatory Skin Conditions?

Authors:  Deirdre Edge; Maiken Mellergaard; Carsten Dam-Hansen; Dennis Dan Corell; Joanna Jaworska; Giovanni Scapagnini; Michael Canova Engelbrecht Nielsen
Journal:  J Clin Aesthet Dermatol       Date:  2019-05-01

5.  Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-03

Review 6.  The psychological impact of rosacea and the influence of current management options.

Authors:  Farah Moustafa; Robin S Lewallen; Steven R Feldman
Journal:  J Am Acad Dermatol       Date:  2014-07-01       Impact factor: 11.527

7.  Incidence and prevalence of rosacea: a systematic review and meta-analysis.

Authors:  L Gether; L K Overgaard; A Egeberg; J P Thyssen
Journal:  Br J Dermatol       Date:  2018-05-31       Impact factor: 9.302

8.  Treatment of solar lentigines using a combination of picosecond laser and biophotonic treatment.

Authors:  Giuseppe Scarcella; Markus Wied Dethlefsen; Michael Canova Engelbrecht Nielsen
Journal:  Clin Case Rep       Date:  2018-08-09

9.  Treatment of granulomatous rosacea with chromophore gel-assisted phototherapy.

Authors:  Rose C Liu; Mani Makhija; Xin L Wong; Deshan F Sebaratnam
Journal:  Photodermatol Photoimmunol Photomed       Date:  2019-03-27       Impact factor: 3.135

Review 10.  Rosacea: Epidemiology, pathogenesis, and treatment.

Authors:  Barbara M Rainer; Sewon Kang; Anna L Chien
Journal:  Dermatoendocrinol       Date:  2017-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.